Cardeas Pharma Report issue

For profit Phase 2
Founded: Seattle WA United States (2010)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2013
NCT01969799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

amikacin (Amikin) (3 trials)

fosfomycin (monurol) (3 trials)

sodium chloride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 2)

Pneumonia, Bacterial (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3